[go: up one dir, main page]

DK0537191T3 - Behandling af organtransplantat-afstødning - Google Patents

Behandling af organtransplantat-afstødning

Info

Publication number
DK0537191T3
DK0537191T3 DK91910880T DK91910880T DK0537191T3 DK 0537191 T3 DK0537191 T3 DK 0537191T3 DK 91910880 T DK91910880 T DK 91910880T DK 91910880 T DK91910880 T DK 91910880T DK 0537191 T3 DK0537191 T3 DK 0537191T3
Authority
DK
Denmark
Prior art keywords
treatment
graft rejection
organ graft
fluoro
carboxylic acid
Prior art date
Application number
DK91910880T
Other languages
Danish (da)
English (en)
Inventor
Neil Richard Ackerman
Bruce Donald Jaffee
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Application granted granted Critical
Publication of DK0537191T3 publication Critical patent/DK0537191T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK91910880T 1990-06-11 1991-06-05 Behandling af organtransplantat-afstødning DK0537191T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/535,672 US5204329A (en) 1990-06-11 1990-06-11 Treatment of organ transplantation rejection
PCT/US1991/003788 WO1991019498A1 (fr) 1990-06-11 1991-06-05 Traitement contre le rejet du greffon

Publications (1)

Publication Number Publication Date
DK0537191T3 true DK0537191T3 (da) 1998-10-07

Family

ID=24135268

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91910880T DK0537191T3 (da) 1990-06-11 1991-06-05 Behandling af organtransplantat-afstødning

Country Status (14)

Country Link
US (1) US5204329A (fr)
EP (1) EP0537191B1 (fr)
JP (1) JPH05507697A (fr)
KR (1) KR930700107A (fr)
AT (1) ATE165511T1 (fr)
AU (1) AU664354B2 (fr)
CA (1) CA2085002A1 (fr)
DE (1) DE69129332T2 (fr)
DK (1) DK0537191T3 (fr)
ES (1) ES2114888T3 (fr)
IE (1) IE911962A1 (fr)
IL (1) IL98425A (fr)
WO (1) WO1991019498A1 (fr)
ZA (1) ZA914456B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06116151A (ja) * 1991-08-06 1994-04-26 Asahi Chem Ind Co Ltd 増殖性皮膚疾患治療用組成物
US6270766B1 (en) * 1992-10-08 2001-08-07 The Kennedy Institute Of Rheumatology Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
US6770279B1 (en) * 1992-10-08 2004-08-03 The Kennedy Institute Of Rheumatology TNFα antagonists and cyclosporin in therapy of rheumatoid arthritis
US5409886A (en) * 1993-02-18 1995-04-25 Mitsui Toatsu Chemicals, Incorporated 3-pyrroline-2-one derivatives and herbicidal compositions containing same
US6171585B1 (en) 1993-05-14 2001-01-09 Cedars-Sinai Medical Center IVIg immunosuppression in HLA-sensitized transplant recipients
US20020068057A1 (en) * 1994-03-10 2002-06-06 Marc Feldmann Treatment of autoimmune and inflammatory disorders
US5578609A (en) * 1994-03-25 1996-11-26 The Dupont Merck Pharmaceutical Company 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents
US5627193A (en) * 1995-02-09 1997-05-06 Mitsui Toatsu Chemicals, Inc. Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds
WO1997042953A1 (fr) * 1996-05-10 1997-11-20 Novartis Ag Utilisation de brequinar et de derives contre le rejet chronique de greffes allogeniques et la xenotransplantation
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6376670B1 (en) 1997-06-19 2002-04-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
EP0991623A2 (fr) 1997-06-19 2000-04-12 Sepracor, Inc. Agents antimicrobiens quinoleine-indole, utilisations et compositions associees
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
UA65587C2 (en) * 1997-10-09 2004-04-15 Baker Norton Pharma Method for preventing nephrotoxicity induced by cyclosporins or tacrolimus
AU2108099A (en) * 1998-01-30 1999-08-16 Procept, Inc. Immunosuppressive agents
TW581681B (en) * 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
US6608045B2 (en) * 1998-03-27 2003-08-19 Chong Kun Dang Corporation Streptomyces sp producing tautomycetin and immunosuppressant comprising tautomycetin as active ingredient
US7323471B1 (en) * 1999-08-13 2008-01-29 Dor Biopharma, Inc. Topical azathioprine for the treatment of oral autoimmune diseases
US20160287549A1 (en) 2013-11-22 2016-10-06 Genzyme Corporation Novel methods for treating neurodegenerative diseases
NZ723107A (en) * 2014-02-07 2022-11-25 Neurocrine Biosciences Inc Pharmaceutical compositions comprising an antipsychotic drug and a vmat2 inhibitor and uses thereof
US11406707B2 (en) * 2014-02-10 2022-08-09 H. Lee Moffitt Cancer Center And Research Institute, Inc. STAT3 phosphorylation during graft-versus-host disease
CA3002074A1 (fr) 2015-10-30 2017-05-04 Neurocrine Biosciences, Inc. Sels de valbenazine et polymorphes associes
CA3009169A1 (fr) 2015-12-23 2017-06-29 Neurocrine Biosciences, Inc. Procedes de synthese pour la preparation de di(4-methylbenzenesulfonate) de 2-amino-3-methylbutanoate de (s)-(2r,3r,11br)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1h-pyri do[2,1-a]isoquinolein-2-yl
KR20190108149A (ko) 2017-01-27 2019-09-23 뉴로크린 바이오사이언시즈 인코퍼레이티드 특정 vmat2 억제제의 투여 방법
BR112020005373A2 (pt) 2017-09-21 2020-09-24 Neurocrine Biosciences Inc. formulação de valbenazina em alta dosagem e composições, métodos e kits relacionados com valbenazina
CA3077149A1 (fr) 2017-10-10 2019-04-18 Neurocrine Biosciences, Inc. Methodes d'administration de (s)-2-amino-3-methyle-acide butyrique(2r,3r,11br)-3-isobutyle-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinoline-2yl ester et de sels connexe
KR20250070134A (ko) 2017-10-10 2025-05-20 뉴로크린 바이오사이언시즈 인코퍼레이티드 특정 vmat2 억제제의 투여 방법
WO2020037022A1 (fr) 2018-08-15 2020-02-20 Neurocrine Biosciences, Inc. Procédés d'administration de certains inhibiteurs de vmat2
US10940141B1 (en) 2019-08-23 2021-03-09 Neurocrine Biosciences, Inc. Methods for the administration of certain VMAT2 inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6592M (fr) * 1967-10-31 1968-12-30
GB1334705A (en) * 1970-06-19 1973-10-24 Ici Ltd Pharmaceutical compositions containing kynurenic acid derivatives
CH576963A5 (fr) * 1972-03-10 1976-06-30 Ciba Geigy Ag
DE2449030A1 (de) * 1974-10-11 1976-05-20 Schering Ag Neue pyridin-derivate
US4407803A (en) * 1981-08-17 1983-10-04 Abbott Laboratories Antiinflammatory 1-(quinolinyl)-2-pyrazoline derivatives
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
FI75308C (sv) * 1985-01-25 1988-06-09 Ky Carlson Project Kb Hydrostatiskt drivsystem.
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
US4661499A (en) * 1985-06-18 1987-04-28 Merck Frosst Canada, Inc. 2-[(substituted)-phenoxymethyl]quinolines
GB8602372D0 (en) * 1986-01-31 1986-03-05 Sandoz Ltd Organic compounds
US4851409A (en) * 1986-02-14 1989-07-25 Merck Frosst Canada Inc. 2-substituted quinoline dioic acids and pharmaceutical compositions
US4847381A (en) * 1987-08-31 1989-07-11 American Cyanamid Company 2-Phenyl-4-quinoline carboxylic acids
US4861783A (en) * 1988-04-26 1989-08-29 E. I. Du Pont De Nemours And Company 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases
US4968701A (en) * 1988-04-26 1990-11-06 E. I. Du Pont De Nemours And Company 4-Quinoline carboxylic acid derivatives useful as immunosuppressive agents
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
IL98425A (en) 1995-06-29
AU8087391A (en) 1992-01-07
ZA914456B (en) 1993-02-24
EP0537191B1 (fr) 1998-04-29
DE69129332T2 (de) 1998-08-27
US5204329A (en) 1993-04-20
IE911962A1 (en) 1991-12-18
EP0537191A4 (en) 1993-08-11
ATE165511T1 (de) 1998-05-15
AU664354B2 (en) 1995-11-16
CA2085002A1 (fr) 1991-12-12
EP0537191A1 (fr) 1993-04-21
JPH05507697A (ja) 1993-11-04
KR930700107A (ko) 1993-03-13
DE69129332D1 (de) 1998-06-04
WO1991019498A1 (fr) 1991-12-26
ES2114888T3 (es) 1998-06-16

Similar Documents

Publication Publication Date Title
DK0537191T3 (da) Behandling af organtransplantat-afstødning
DE69101788D1 (de) Hochsymmetrischer gleichstrom-squid.
DK0484281T4 (da) Cyclosporiner
DK0745074T3 (da) 4-Aminoderivater af mycophenolsyre med immunsuppressiv virkning
NL300224I1 (nl) 3-Benzazepinzonen gesubstitueerd met een benzocyclobutyl-of indanylalkyla-minoalkylgroep, bruikbaar voor de behandeling van cardiovasculaire aandoeningen.
DK0788513T3 (da) Anvendelse af bindingsmidler for CD23 i behandlingen af atoimmune sygdomme
FR2659998B1 (fr) Support de raccord d'evacuation de plancher.
MY106038A (en) 4-quinoline carboxylic acid derivatives useful as immunosuppressive agents.
BR9102153A (pt) Porta-esferas de mancal de rolamento
AU8216691A (en) Autobiotics and their use in eliminating nonself cells in vivo
FI931204A0 (fi) Nya, saosom lipooxigenasinhibitorer verkande aminobensosultamderivat
DE3875306D1 (de) Immunosuppression bei der auf immunotoxin basierten behandlung von menschen.
DE69112192D1 (de) Antiherpes-Castanosperminester.
DE69108668D1 (de) Kugelgelenkprothese.
DE69110323D1 (de) Mikroskopobjektiv.
ATE210126T1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
DK0745072T3 (da) 4-aminoderivater af 5-substitueret mycophenolsyre
TR26931A (tr) Lak koagülasyonunda molipten bilesiklerinin kullanilmasi.
DE59102569D1 (de) Sulfierte hydroxycarbonsäureester.
DE69103824D1 (de) Patientenliegetische.
EP0653208A3 (fr) Antagonistes de la substance P pour le traitement et la prévention de l'erythème solaire.
ITRM920460A1 (it) Dispositivo articolatore con adattamento automatico.
FI973259A7 (fi) LCK-SH2-spesifisten yhdisteiden käyttö hoidettaessa autoimmuunisairauk sia ja kudossiirrännäisten hyljintää
RU96103721A (ru) Антгельминтное средство
NO20016326D0 (no) Anvendelse av proteinet UK 114 for å hindre avstötning av organtransplantatet